0001415889-24-016108.txt : 20240607 0001415889-24-016108.hdr.sgml : 20240607 20240607214516 ACCESSION NUMBER: 0001415889-24-016108 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240529 FILED AS OF DATE: 20240607 DATE AS OF CHANGE: 20240607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thomas John CENTRAL INDEX KEY: 0001939103 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41599 FILM NUMBER: 241031360 MAIL ADDRESS: STREET 1: C/O GENELUX CORPORATION STREET 2: 2625 TOWNSGATE ROAD, SUITE 230 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENELUX Corp CENTRAL INDEX KEY: 0001231457 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2625 TOWNSGATE ROAD, SUITE 230 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 BUSINESS PHONE: 805-267-9889 MAIL ADDRESS: STREET 1: 2625 TOWNSGATE ROAD, SUITE 230 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 FORMER COMPANY: FORMER CONFORMED NAME: GENELUX CORP DATE OF NAME CHANGE: 20030508 4 1 form4-06072024_090608.xml X0508 4 2024-05-29 0001231457 GENELUX Corp GNLX 0001939103 Thomas John C/O GENELUX CORPORATION 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361 true false false false 0 Common Stock 2024-05-29 4 P 0 2500 A 465960 D Common Stock Warrant (Right to Buy) 5.25 2024-05-29 4 P 0 2500 A 2024-05-29 2029-05-29 Common Stock 2500 2500 D The Reporting Person's purchase reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the Reporting Person's sale of common stock on December 13, 2023. The Reporting Person has agreed to pay to the Issuer the profit realized in connection with the short-swing transaction, less transaction costs. The reported securities consist of shares of common stock sold together with accompanying warrants to purchase common stock. The combined price of each share of common stock offered together with one warrant was $4.00. /s/ Thomas Zindrick, J.D., Attorney-in-Fact 2024-06-07